Market Overview

Trade CNS stock with recommended broker Ally Invest. Commissions as low as $3.95.

Analyst Rating View All Ratings

DateResearch FirmActionCurrentTarget
4/16/18Gabelli & Co.UpgradesHoldBuy
1/26/18Keefe Bruyette & WoodsDowngradesMarket PerformUnderperform
1/11/18Gabelli & Co.DowngradesBuyHold
Show more Loading articles...

Earnings View Earnings

Q1 2018 EST Actual Surprise
EPS: 0.62 0.62 0
Rev: 98.17M 94.46M -3.71M
Q2 2018 EST Actual Surprise
EPS: Expected
2018-07-18
Rev:

Company Profile